Prokineticins (endocrine gland-VEGF and BV8) in the bovine ovary: Expression and role as mitogens and survival factors for corpus luteum derived- endothelial cells

Endocrinology

Volumn 146, Issue 9, 2005, Pages 3950-3958

  Kisliouk, Tatiana ^a   Podlovni, Helena ^a   Spanel Borowski, Katharina ^b   Ovadia, Oded ^a   Zhou, Qun Yong ^c   Meidan, Rina ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Apoptosis; Luteal endothelial cells; Luteal steroidogenic cells; VEGF

Indexed keywords

CASPASE 3; DNA FRAGMENT; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGENIC AGENT; THYMIDINE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CELL HYPOXIA; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; CORPUS LUTEUM; COW; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME DEGRADATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOGENESIS; NICK END LABELING; NUCLEOTIDE SEQUENCE; OVARY CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STARVATION; STEROIDOGENESIS;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BASE SEQUENCE; CATTLE; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; CORPUS LUTEUM; CULTURE MEDIA, SERUM-FREE; FEMALE; GRANULOSA CELLS; MAP KINASE SIGNALING SYSTEM; MITOGENS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, MESSENGER; THECA CELLS; THYMIDINE; TRITIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED;

EID: 23844458338     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2005-0297     Document Type: Article

References (54)

1. Li M, Bullock CM, Knauer DJ, Ehlert FJ, Zhou QY 2001 Identification of two prokineticin cDNAs: recombinant proteins potently contract gastrointestinal smooth muscle. Mol Pharmacol 59:692-698
2. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L, Frantz G, Rangell L, DeGuzman L, Keller GA, Peale F, Gurney A, Hillan KJ, Ferrara N 2001 Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412:877-884
3. Cheng MY, Bullock CM, Li C, Lee AG, Bermak JC, Belluzzi J, Weaver DR, Leslie FM, Zhou QY 2002 Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 417:405-410
4. Negri L, Lattanzi R, Giannini E, Metere A, Colucci M, Barra D, Kreil G, Melchiorri P 2002 Nociceptive sensitization by the secretory protein Bv8. Br J Pharmacol 137:1147-1154
5. Negri L, Lattanzi R, Giannini E, De Felice M, Colucci A, Melchiorri P 2004 Bv8, the amphibian homologue of the mammalian prokineticins, modulates ingestive behaviour in rats. Br J Pharmacol 142:181-191
6. LeCouter J, Zlot C, Tejada M, Peale F, Ferrara N 2004 Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc Natl Acad Sci U S A 101:16813-16818
7. Cottrell GT, Zhou QY, Ferguson AV 2004 Prokineticin 2 modulates the excitability of subfornical organ neurons. J Neurosci 24:2375-2379
8. Battersby S, Critchley HO, Morgan K, Millar RP, Jabbour HN 2004 Expression and regulation of the prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) and their receptors in the human endometrium across the menstrual cycle. J Clin Endocrinol Metab 89:2463-2469
9. Kaser A, Winklmayr M, Lepperdinger G, Kreil G 2003 The AVIT protein family. Secreted cysteine-rich vertebrate proteins with diverse functions. EMBO Rep 4:469-473
10. Lin DC, Bullock CM, Ehlert FJ, Chen JL, Tian H, Zhou QY 2002 Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J Biol Chem 277:19276-19280
11. Masuda Y, Takatsu Y, Terao Y, Kumano S, Ishibashi Y, Suenaga M, Abe M, Fukusumi S, Watanabe T, Shintani Y, Yamada T, Hinuma S, Inatomi N, Ohtaki T, Onda H, Fujino M 2002 Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan Gprotein-coupled receptors. Biochem Biophys Res Commun 293:396-402
12. Soga T, Matsumoto S, Oda T, Saito T, Hiyama H, Takasaki J, Kamohara M, Ohishi T, Matsushime H, Furuichi K 2002 Molecular cloning and characterization of prokineticin receptors. Biochim Biophys Acta 1579:173-179
13. Lin R, LeCouter J, Kowalski J, Ferrara N 2002 Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells. J Biol Chem 277:8724-8729
14. LeCouter J, Lin R, Tejada M, Frantz G, Peale F, Hillan KJ, Ferrara N 2003 The endocrinegland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells. Proc Natl Acad Sci U S A 100:2685-2690
15. Ferrara N, Frantz G, LeCouter J, Dillard-Telm L, Pham T, Draksharapu A, Giordano T, Peale F 2003 Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. Am J Pathol 162:1881-1893
16. Kisliouk T, Levy N, Hurwitz A, Meidan R 2003 Presence and regulation of endocrine glandvascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells. J Clin Endocrinol Metab 88:3700-3707
17. Fraser HM, Bell J, Wilson H, Taylor PD, Morgan K, Anderson RA, Duncan WC 2005 Localization and Quantification of Cyclic Changes in the Expression of Endocrine Gland Vascular Endothelial Growth Factor in the Human Corpus Luteum. J Clin Endocrinol Metab 90:427-434
18. Zheng J, Redmer DA, Reynolds LP 1993 Vascular development and heparin-binding growth factors in the bovine corpus luteum at several stages of the estrous cycle. Biol Reprod 49:1177-1189
19. Redmer DA, Doraiswamy V, Bortnem BJ, Fisher K, Jablonka-Shariff A, Grazul-Bilska AT, Reynolds LP 2001 Evidence for a role of capillary pericytes in vascular growth of the developing ovine corpus luteum. Biol Reprod 65:879-889
20. Young FM, Rodger FE, Illingworth PJ, Fraser HM 2000 Cell proliferation and vascular morphology in the marmoset corpus luteum. Hum Reprod 15:557-566
21. Stouffer RL, Martinez-Chequer JC, Molskness TA, Xu F, Hazzard TM 2001 Regulation and action of angiogenic factors in the primate ovary. Arch Med Res 32:567-575
22. Berisha B, Schams D, Kosmann M, Amselgruber W, Einspanier R 2000 Expression and tissue concentration of vascular endothelial growth factor, its receptors, and localization in the bovine corpus luteum during estrous cycle and pregnancy. Biol Reprod 63:1106-1114
23. Sugino N, Kashida S, Takiguchi S, Karube A, Kato H 2000 Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab 85:3919-3924
24. Augustin HG 2000 Vascular morphogenesis in the ovary. Baillieres Best Pract Res Clin Obstet Gynaecol 14:867-882
25. Schams D, Berisha B 2004 Regulation of corpus luteum function in cattle - an overview. Reprod Domest Anim 39:241-251
26. Fields MJ, Fields PA 1996 Morphological characteristics of the bovine corpus luteum during the estrous cycle and pregnancy. Theriogenology 45:1295-1325
27. Fenyves AM, Behrens J, Spanel-Borowski K 1993 Cultured microvascular endothelial cells (MVEC) differ in cytoskeleton, expression of cadherins and fibronectin matrix. A study under the influence of interferon-gamma. J Cell Sci 106 (Pt 3):879-890
28. Lehmann I, Brylla E, Sittig D, Spanel-Borowski K, Aust G 2000 Microvascular endothelial cells differ in their basal and tumour necrosis factor-alpha-regulated expression of adhesion molecules and cytokines. J Vasc Res 37:408-416
29. Levy N, Gordin M, Smith MF, Bolden-Tiller OU, Meidan R 2003 Hormonal regulation and cellspecific expression of endothelin-converting enzyme 1 isoforms in bovine ovarian endothelial and steroidogenic cells. Biol Reprod 68:1361-8
30. Levy N, Gordin M, Mamluk R, Yanagisawa M, Smith MF, Hampton JH, Meidan R 2001 Distinct cellular localization and regulation of endothelin-1 and endothelin-converting enzyme-1 expression in the bovine corpus luteum: implications for luteolysis. Endocrinology 142:5254-5260
31. Meidan R, Girsh E, Blum O, Aberdam E 1990 In vitro differentiation of bovine theca and granulosa cells into small and large luteal-like cells: morphological and functional characteristics. Biol Reprod 43:913-921
32. Klipper E, Gilboa T, Levy N, Kisliouk T, Spanel-Borowski K, Meidan R 2004 Characterization of endothelin-1 and nitric oxide generating systems in corpus luteum-derived endothelial cells. Reproduction 128:463-473
33. Friedman A, Weiss S, Levy N, Meidan R 2000 Role of tumor necrosis factor alpha and its type I receptor in luteal regression: induction of programmed cell death in bovine corpus luteumderived endothelial cells. Biol Reprod 63:1905-1912
34. Choi KS, Bae MK, Jeong JW, Moon HE, Kim KW 2003 Hypoxia-induced angiogenesis during carcinogenesis. J Biochem Mol Biol 36:120-127
35. Harris AL 2002 Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2:38-47
36. Widmann C, Gibson S, Jarpe MB, Johnson GL 1999 Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79:143-180
37. Shaulian E, Karin M 2002 AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-136
38. Sng JC, Taniura H, Yoneda Y 2004 A tale of early response genes. Biol Pharm Bull 27:606-612
39. Chen DB, Davis JS 2003 Epidermal growth factor induces c-fos and c-jun mRNA via Raf-1/MEK1/ERK-dependent and -independent pathways in bovine luteal cells. Mol Cell Endocrinol 200:141-154
40. Boatright KM, Salvesen GS 2003 Mechanisms of caspase activation. Curr Opin Cell Biol 15:725-731
41. Mamluk R, Wolfenson D, Meidan R 1998 LH receptor mRNA and cytochrome P450 side-chain cleavage expression in bovine theca and granulosa cells luteinized by LH or forskolin. Domest Anim Endocrinol 15:103-114
42. Mamluk R, Chen D, Greber Y, Davis JS, Meidan R 1998 Characterization of messenger ribonucleic acid expression for prostaglandin F2 alpha and luteinizing hormone receptors in various bovine luteal cell types. Biol Reprod 58:849-856
43. Smith MF, McIntush EW, Smith GW 1994 Mechanisms associated with corpus luteum development. J Anim Sci 72:1857-1872
44. Blagosklonny MV, Pardee AB 2002 The restriction point of the cell cycle. Cell Cycle 1:103-10
45. Cheng M, Sexl V, Sherr CJ, Roussel MF 1998 Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci U S A 95:1091-1096
46. Johnson AL, Bridgham JT 2002 Caspase-mediated apoptosis in the vertebrate ovary. Reproduction 124:19-27
47. Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kagi D, Hakem A, McCurrach M, Khoo W, Kaufman SA, Senaldi G, Howard T, Lowe SW, Mak TW 1998 Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 12:806-819
48. Carambula SF, Matikainen T, Lynch MP, Flavell RA, Goncalves PB, Tilly JL, Rueda BR 2002 Caspase-3 is a pivotal mediator of apoptosis during regression of the ovarian corpus luteum. Endocrinology 143:1495-1501
49. LeCouter J, Lin R, Frantz G, Zhang Z, Hillan K, Ferrara N 2003 Mouse endocrine glandderived vascular endothelial growth factor: a distinct expression pattern from its human ortholog suggests different roles as a regulator of organ-specific angiogenesis. Endocrinology 144:2606-2616
50. Wulff C, Wilson H, Rudge JS, Wiegand SJ, Lunn SF, Fraser HM 2001 Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40). J Clin Endocrinol Metab 86:3377-3386
51. Hazzard TM, Rohan RM, Molskness TA, Fanton JW, D'Amato RJ, Stouffer RL 2002 Injection of antiangiogenic agents into the macaque preovulatory follicle: disruption of corpus luteum development and function. Endocrine 17:199-206
52. Hazzard TM, Stouffer RL 2000 Angiogenesis in ovarian follicular and luteal development. Baillieres Best Pract Res Clin Obstet Gynaecol 14:883-900
53. Wulff C, Wilson H, Wiegand SJ, Rudge JS, Fraser HM 2002 Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2. Endocrinology 143:2797-2807
54. Fraser HM, Wulff C 2001 Angiogenesis in the primate ovary. Reprod Fertil Dev 13:557-566